Pharmacy diabetes care program of self-monitoring of blood glucose: Cross-over trial

Pharmacy diabetes care program of self-monitoring of blood glucose: Cross-over trial - COMPASS-SEP

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016074

Enrollment

Registered

2015-02-01

Start date

2015-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

Self-monitoring blood glucose: 7 times a day Self-monitoring blood glucose: 2 times a day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Type 2 diabetes higher than HbA1c 7% over 3 months

Exclusion criteria

Exclusion criteria: patients with insulin/GLP-1 therapy kidny disease, dialyzed patient

Design outcomes

Primary

Measure	Time frame
HbA1c	—

Secondary

Measure	Time frame
Adherence, Changes in daily eating and exercise habits	—

Countries

Japan

Contacts

Public ContactHiroshi OKADA

National Hospital Organization Kyoto Medical Center Department of Preventive Medicine Clinical Research Institute for Endocrine and Metabolic disease

bufobufo.ok@gmail.com075-641-9161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026